Countermeasures to the supply chain disruptions in medical and pharmaceutical industries

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 170653

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $93,035.66
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principle Investigator

    Pending
  • Research Location

    Canada, Americas
  • Lead Research Institution

    York University
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Other secondary impacts

  • Special Interest Tags

    Gender

  • Study Subject

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The intended research project focuses on the supply chain disruptions that medical/pharmaceutical industries are currently facing in the Novel Coronavirus Outbreak, due to the suppliers' strategic hoarding and consumers' panic buying behavior under psychological and behavioral uncertainties. Specifically, this proposed research project explores: factors that delay the resilience of medical/pharmaceutical industries' supply chain disruptions caused by the Novel Coronavirus Outbreak; and the feasibility of two countermeasures to the virus outbreak that we propose: (1) establishing a collaborative stock sharing/transshipment system; and (2) making an incentive contract with a potential second source that can produce highly customized medical/pharmaceutical items (e.g., protective clothing for or a new drug for novel viruses).